Novo Nordisk and Oxford University Team Up to Develop Novel Treatments for Rheumatoid Arthritis and Other Inflammatory Diseases

Today, Novo Nordisk and the Kennedy Institute of Rheumatology at Oxford University jointly announced a new partnership to develop promising new drug candidates and identify novel biomarkers and...Read…
Read the full story: Biomarker Commons